256 related articles for article (PubMed ID: 19164443)
1. Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.
Iacovelli L; Molinaro G; Battaglia G; Motolese M; Di Menna L; Alfiero M; Blahos J; Matrisciano F; Corsi M; Corti C; Bruno V; De Blasi A; Nicoletti F
Mol Pharmacol; 2009 Apr; 75(4):991-1003. PubMed ID: 19164443
[TBL] [Abstract][Full Text] [Related]
2. Desensitization and internalization of metabotropic glutamate receptor 1a following activation of heterologous Gq/11-coupled receptors.
Mundell SJ; Pula G; McIlhinney RA; Roberts PJ; Kelly E
Biochemistry; 2004 Jun; 43(23):7541-51. PubMed ID: 15182196
[TBL] [Abstract][Full Text] [Related]
3. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
Seeman P; Battaglia G; Corti C; Corsi M; Bruno V
Synapse; 2009 Mar; 63(3):247-51. PubMed ID: 19084908
[TBL] [Abstract][Full Text] [Related]
4. mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage.
Ciceroni C; Mosillo P; Mastrantoni E; Sale P; Ricci-Vitiani L; Biagioni F; Stocchi F; Nicoletti F; Melchiorri D
Glia; 2010 May; 58(7):813-22. PubMed ID: 20091783
[TBL] [Abstract][Full Text] [Related]
5. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
6. Selective regulation of recombinantly expressed mGlu7 metabotropic glutamate receptors by G protein-coupled receptor kinases and arrestins.
Iacovelli L; Felicioni M; Nisticò R; Nicoletti F; De Blasi A
Neuropharmacology; 2014 Feb; 77():303-12. PubMed ID: 24148810
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
[TBL] [Abstract][Full Text] [Related]
8. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.
Corti C; Battaglia G; Molinaro G; Riozzi B; Pittaluga A; Corsi M; Mugnaini M; Nicoletti F; Bruno V
J Neurosci; 2007 Aug; 27(31):8297-308. PubMed ID: 17670976
[TBL] [Abstract][Full Text] [Related]
9. Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis.
Dhami GK; Ferguson SS
Pharmacol Ther; 2006 Jul; 111(1):260-71. PubMed ID: 16574233
[TBL] [Abstract][Full Text] [Related]
10. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
12. The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
Ngomba RT; Biagioni F; Casciato S; Willems-van Bree E; Battaglia G; Bruno V; Nicoletti F; van Luijtelaar EL
Neuropharmacology; 2005; 49 Suppl 1():89-103. PubMed ID: 16043198
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
14. mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists.
Zammataro M; Chiechio S; Montana MC; Traficante A; Copani A; Nicoletti F; Gereau RW
Mol Pain; 2011 Jan; 7():6. PubMed ID: 21235748
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced internalization of leukotriene B(4) receptor 1 requires G-protein-coupled receptor kinase 2 but not arrestins.
Chen Z; Gaudreau R; Le Gouill C; Rola-Pleszczynski M; Stanková J
Mol Pharmacol; 2004 Sep; 66(3):377-86. PubMed ID: 15322228
[TBL] [Abstract][Full Text] [Related]
16. Specificity of g protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell m3 muscarinic acetylcholine receptor signaling.
Willets JM; Mistry R; Nahorski SR; Challiss RA
Mol Pharmacol; 2003 Nov; 64(5):1059-68. PubMed ID: 14573754
[TBL] [Abstract][Full Text] [Related]
17. Translational Pharmacology of the Metabotropic Glutamate 2 Receptor-Preferring Agonist LY2812223 in the Animal and Human Brain.
Felder CC; Schober DA; Tu Y; Quets A; Xiao H; Watt M; Siuda E; Nisenbaum E; Xiang C; Heinz B; Prieto L; McKinzie DL; Monn JA
J Pharmacol Exp Ther; 2017 Apr; 361(1):190-197. PubMed ID: 28138041
[TBL] [Abstract][Full Text] [Related]
18. Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.
Hanna L; Ceolin L; Lucas S; Monn J; Johnson B; Collingridge G; Bortolotto Z; Lodge D
Neuropharmacology; 2013 Mar; 66():114-21. PubMed ID: 22445601
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
Arcella A; Carpinelli G; Battaglia G; D'Onofrio M; Santoro F; Ngomba RT; Bruno V; Casolini P; Giangaspero F; Nicoletti F
Neuro Oncol; 2005 Jul; 7(3):236-45. PubMed ID: 16053698
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor mGlu2 is resistant to homologous agonist-induced desensitization but undergoes protein kinase C-mediated heterologous desensitization.
Lennon SM; Rivero G; Matharu A; Howson PA; Jane DE; Roberts PJ; Kelly E
Eur J Pharmacol; 2010 Dec; 649(1-3):29-37. PubMed ID: 20826132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
